Literature DB >> 31091127

Knockout of Na+-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration.

Panai Song1,2, Winnie Huang2, Akira Onishi1,2, Rohit Patel2, Young Chul Kim1,2, Charlotte van Ginkel1,2, Yiling Fu2, Brent Freeman2, Hermann Koepsell3, Scott Thomson1,2, Ruisheng Liu4, Volker Vallon1,2,5.   

Abstract

Na+-glucose cotransporter (SGLT)1 mediates glucose reabsorption in late proximal tubules. SGLT1 also mediates macula densa (MD) sensing of an increase in luminal glucose, which increases nitric oxide (NO) synthase 1 (MD-NOS1)-mediated NO formation and potentially glomerular filtratrion rate (GFR). Here, the contribution of SGLT1 was tested by gene knockout (-/-) in type 1 diabetic Akita mice. A low-glucose diet was used to prevent intestinal malabsorption in Sglt1-/- mice and minimize the contribution of intestinal SGLT1. Hyperglycemia was modestly reduced in Sglt1-/- versus littermate wild-type Akita mice (480 vs. 550 mg/dl), associated with reduced diabetes-induced increases in GFR, kidney weight, glomerular size, and albuminuria. Blunted hyperfiltration was confirmed in streptozotocin-induced diabetic Sglt1-/- mice, associated with similar hyperglycemia versus wild-type mice (350 vs. 385 mg/dl). Absence of SGLT1 attenuated upregulation of MD-NOS1 protein expression in diabetic Akita mice and in response to SGLT2 inhibition in nondiabetic mice. During SGLT2 inhibition in Akita mice, Sglt1-/- mice had likewise reduced blood glucose (200 vs. 300 mg/dl), associated with lesser MD-NOS1 expression, GFR, kidney weight, glomerular size, and albuminuria. Absence of Sglt1 in Akita mice increased systolic blood pressure, associated with suppressed renal renin mRNA expression. This may reflect fluid retention due to blunted hyperfiltration. SGLT2 inhibition prevented the blood pressure increase in Sglt1-/- Akita mice, possibly due to additive glucosuric/diuretic effects. The data indicate that SGLT1 contributes to diabetic hyperfiltration and limits diabetic hypertension. Potential mechanisms include its role in glucose-driven upregulation of MD-NOS1 expression. This pathway may increase GFR to maintain volume balance when enhanced MD glucose delivery indicates upstream saturation of SGLTs and thus hyperreabsorption.

Entities:  

Keywords:  Na-glucose cotransporter 2; diabetes mellitus; glomerular hyperfiltration; hypertension; neuronal nitric oxide synthase

Mesh:

Substances:

Year:  2019        PMID: 31091127      PMCID: PMC6692722          DOI: 10.1152/ajprenal.00120.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  44 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Nitric oxide synthase in macula densa regulates glomerular capillary pressure.

Authors:  C S Wilcox; W J Welch; F Murad; S S Gross; G Taylor; R Levi; H H Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Expression of nitric oxide synthase in kidney macula densa cells.

Authors:  P Mundel; S Bachmann; M Bader; A Fischer; W Kummer; B Mayer; W Kriz
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

4.  Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice.

Authors:  Volker Vallon; Timothy Traynor; Luciano Barajas; Yuning G Huang; Josie P Briggs; Jürgen Schnermann
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

5.  Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.

Authors:  V Vallon; K Richter; R C Blantz; S Thomson; H Osswald
Journal:  J Am Soc Nephrol       Date:  1999-12       Impact factor: 10.121

6.  Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.

Authors:  G Vervoort; B Veldman; J H M Berden; P Smits; J F M Wetzels
Journal:  Eur J Clin Invest       Date:  2005-05       Impact factor: 4.686

7.  Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback.

Authors:  Ruisheng Liu; Oscar A Carretero; YiLin Ren; Jeffrey L Garvin
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

8.  Temporal adjustment of the juxtaglomerular apparatus during sustained inhibition of proximal reabsorption.

Authors:  S C Thomson; S Bachmann; M Bostanjoglo; C A Ecelbarger; O W Peterson; D Schwartz; D Bao; R C Blantz
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

9.  Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.

Authors:  R Komers; J N Lindsley; T T Oyama; K M Allison; S Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

10.  Early diabetes as a model for testing the regulation of juxtaglomerular NOS I.

Authors:  Scott C Thomson; Aihua Deng; Norikuni Komine; John S Hammes; Roland C Blantz; Francis B Gabbai
Journal:  Am J Physiol Renal Physiol       Date:  2004-06-22
View more
  23 in total

Review 1.  Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.

Authors:  Scott C Thomson; Volker Vallon
Journal:  Am J Cardiol       Date:  2019-12-15       Impact factor: 2.778

2.  Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.

Authors:  Akira Onishi; Yiling Fu; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Rohit Patel; Young Chul Kim; Josselin Nespoux; Brent Freeman; Manoocher Soleimani; Scott Thomson; Kumar Sharma; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-05

3.  Knockout of Macula Densa Neuronal Nitric Oxide Synthase Increases Blood Pressure in db/db Mice.

Authors:  Jie Zhang; Ximing Wang; Yu Cui; Shan Jiang; Jin Wei; Jenna Chan; Anish Thalakola; Thanh Le; Lan Xu; Liang Zhao; Lei Wang; Kun Jiang; Feng Cheng; Trushar Patel; Jacentha Buggs; Volker Vallon; Ruisheng Liu
Journal:  Hypertension       Date:  2021-10-18       Impact factor: 10.190

Review 4.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

5.  Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion.

Authors:  Josselin Nespoux; Rohit Patel; Haiyan Zhang; Winnie Huang; Brent Freeman; Paul W Sanders; Young Chul Kim; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-02

Review 6.  Glucose transporters in the kidney in health and disease.

Authors:  Volker Vallon
Journal:  Pflugers Arch       Date:  2020-03-06       Impact factor: 3.657

Review 7.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

Review 8.  UAB-UCSD O'Brien Center for Acute Kidney Injury Research.

Authors:  Lisa M Curtis; James George; Volker Vallon; Stephen Barnes; Victor Darley-Usmar; Sucheta Vaingankar; Gary R Cutter; Orlando M Gutierrez; Michael Seifert; Joachim H Ix; Ravindra L Mehta; Paul W Sanders; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-29

Review 9.  Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.

Authors:  Jessica A Dominguez Rieg; Jianxiang Xue; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-09       Impact factor: 2.894

10.  Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes.

Authors:  Kana N Miyata; Chao-Sheng Lo; Shuiling Zhao; Xin-Ping Zhao; Isabelle Chenier; Michifumi Yamashita; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.